UniProt ID | AT11A_HUMAN | |
---|---|---|
UniProt AC | P98196 | |
Protein Name | Probable phospholipid-transporting ATPase IH | |
Gene Name | ATP11A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1134 | |
Subcellular Localization |
Cell membrane Multi-pass membrane protein . Early endosome . Recycling endosome . Endoplasmic reticulum . Exit from the endoplasmic reticulum requires the presence of TMEM30A, but not TMEM30B. In the presence of TMEM30A, predominantly located in th |
|
Protein Description | Catalytic component of a P4-ATPase flippase complex which catalyzes the hydrolysis of ATP coupled to the transport of aminophospholipids from the outer to the inner leaflet of various membranes and ensures the maintenance of asymmetric distribution of phospholipids. Phospholipid translocation seems also to be implicated in vesicle formation and in uptake of lipid signaling molecules (Probable). May be involved in the uptake of farnesyltransferase inhibitor drugs, such as lonafarnib.. | |
Protein Sequence | MDCSLVRTLVHRYCAGEENWVDSRTIYVGHREPPPGAEAYIPQRYPDNRIVSSKYTFWNFIPKNLFEQFRRVANFYFLIIFLVQLIIDTPTSPVTSGLPLFFVITVTAIKQGYEDWLRHKADNAMNQCPVHFIQHGKLVRKQSRKLRVGDIVMVKEDETFPCDLIFLSSNRGDGTCHVTTASLDGESSHKTHYAVQDTKGFHTEEDIGGLHATIECEQPQPDLYKFVGRINVYSDLNDPVVRPLGSENLLLRGATLKNTEKIFGVAIYTGMETKMALNYQSKSQKRSAVEKSMNAFLIVYLCILISKALINTVLKYMWQSEPFRDEPWYNQKTESERQRNLFLKAFTDFLAFMVLFNYIIPVSMYVTVEMQKFLGSYFITWDEDMFDEETGEGPLVNTSDLNEELGQVEYIFTDKTGTLTENNMEFKECCIEGHVYVPHVICNGQVLPESSGIDMIDSSPSVNGREREELFFRALCLCHTVQVKDDDSVDGPRKSPDGGKSCVYISSSPDEVALVEGVQRLGFTYLRLKDNYMEILNRENHIERFELLEILSFDSVRRRMSVIVKSATGEIYLFCKGADSSIFPRVIEGKVDQIRARVERNAVEGLRTLCVAYKRLIQEEYEGICKLLQAAKVALQDREKKLAEAYEQIEKDLTLLGATAVEDRLQEKAADTIEALQKAGIKVWVLTGDKMETAAATCYACKLFRRNTQLLELTTKRIEEQSLHDVLFELSKTVLRHSGSLTRDNLSGLSADMQDYGLIIDGAALSLIMKPREDGSSGNYRELFLEICRSCSAVLCCRMAPLQKAQIVKLIKFSKEHPITLAIGDGANDVSMILEAHVGIGVIGKEGRQAARNSDYAIPKFKHLKKMLLVHGHFYYIRISELVQYFFYKNVCFIFPQFLYQFFCGFSQQTLYDTAYLTLYNISFTSLPILLYSLMEQHVGIDVLKRDPTLYRDVAKNALLRWRVFIYWTLLGLFDALVFFFGAYFVFENTTVTSNGQIFGNWTFGTLVFTVMVFTVTLKLALDTHYWTWINHFVIWGSLLFYVVFSLLWGGVIWPFLNYQRMYYVFIQMLSSGPAWLAIVLLVTISLLPDVLKKVLCRQLWPTATERVQTKSQCLSVEQSTIFMLSQTSSSLSF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MDCSLVRTLVH ----CCHHHHHHHHH | 42.08 | 24719451 | |
14 | S-palmitoylation | RTLVHRYCAGEENWV HHHHHHHHCCCCCCC | 3.85 | 19801377 | |
40 | Phosphorylation | PPPGAEAYIPQRYPD CCCCCCCCCCCCCCC | 12.49 | 20736484 | |
45 | Phosphorylation | EAYIPQRYPDNRIVS CCCCCCCCCCCCEEC | 15.08 | 20736484 | |
137 | Ubiquitination | VHFIQHGKLVRKQSR HHHHHCCHHHHHHCC | 41.50 | - | |
187 | Phosphorylation | TASLDGESSHKTHYA EEECCCCCCCCCEEE | 43.18 | 28857561 | |
188 | Phosphorylation | ASLDGESSHKTHYAV EECCCCCCCCCEEEE | 25.38 | 28857561 | |
257 | Ubiquitination | LLRGATLKNTEKIFG EECCCCCCCHHHEEE | 58.42 | - | |
279 | Phosphorylation | ETKMALNYQSKSQKR HHHHHHHCCCHHHHH | 18.27 | 30622161 | |
281 | Phosphorylation | KMALNYQSKSQKRSA HHHHHCCCHHHHHHH | 24.74 | 30622161 | |
283 | Phosphorylation | ALNYQSKSQKRSAVE HHHCCCHHHHHHHHH | 46.29 | 29978859 | |
285 | Acetylation | NYQSKSQKRSAVEKS HCCCHHHHHHHHHHH | 56.25 | 18585829 | |
287 | Phosphorylation | QSKSQKRSAVEKSMN CCHHHHHHHHHHHHH | 43.64 | 19835603 | |
292 | Phosphorylation | KRSAVEKSMNAFLIV HHHHHHHHHHHHHHH | 12.08 | 19835603 | |
300 | Phosphorylation | MNAFLIVYLCILISK HHHHHHHHHHHHHHH | 6.72 | 19835603 | |
306 | Phosphorylation | VYLCILISKALINTV HHHHHHHHHHHHHHH | 14.39 | 20068231 | |
329 | Phosphorylation | PFRDEPWYNQKTESE CCCCCCCCCCCCHHH | 20.59 | - | |
367 | Phosphorylation | IPVSMYVTVEMQKFL CCHHHHHHHHHHHHH | 8.02 | 20068231 | |
436 | Phosphorylation | CCIEGHVYVPHVICN HEEECEEEECEEEEC | 11.55 | - | |
459 | Phosphorylation | GIDMIDSSPSVNGRE CCCCCCCCCCCCHHH | 19.90 | 25159151 | |
488 | Phosphorylation | VQVKDDDSVDGPRKS EECCCCCCCCCCCCC | 29.15 | 28787133 | |
494 | Ubiquitination | DSVDGPRKSPDGGKS CCCCCCCCCCCCCCC | 70.27 | - | |
495 | Phosphorylation | SVDGPRKSPDGGKSC CCCCCCCCCCCCCCE | 29.51 | 20873877 | |
507 | Phosphorylation | KSCVYISSSPDEVAL CCEEEECCCCHHHHH | 36.01 | - | |
529 | Ubiquitination | GFTYLRLKDNYMEIL CCEEEEECHHHHHHH | 37.18 | 21906983 | |
561 | Phosphorylation | DSVRRRMSVIVKSAT HHHHHHHEEEEECCC | 13.59 | 25072903 | |
566 | Phosphorylation | RMSVIVKSATGEIYL HHEEEEECCCCCEEE | 21.84 | 25072903 | |
568 | Phosphorylation | SVIVKSATGEIYLFC EEEEECCCCCEEEEE | 42.30 | 25072903 | |
572 | Phosphorylation | KSATGEIYLFCKGAD ECCCCCEEEEECCCC | 6.88 | 25072903 | |
580 | Phosphorylation | LFCKGADSSIFPRVI EEECCCCCCCCHHHH | 25.46 | 25072903 | |
581 | Phosphorylation | FCKGADSSIFPRVIE EECCCCCCCCHHHHC | 28.88 | 25072903 | |
590 | Ubiquitination | FPRVIEGKVDQIRAR CHHHHCCCHHHHHHH | 29.83 | 21906983 | |
614 | Ubiquitination | RTLCVAYKRLIQEEY HHHHHHHHHHHHHHH | 30.87 | - | |
626 | Ubiquitination | EEYEGICKLLQAAKV HHHHHHHHHHHHHHH | 50.76 | - | |
632 | Ubiquitination | CKLLQAAKVALQDRE HHHHHHHHHHHHHHH | 30.93 | 21890473 | |
641 | Ubiquitination | ALQDREKKLAEAYEQ HHHHHHHHHHHHHHH | 48.45 | - | |
651 | Ubiquitination | EAYEQIEKDLTLLGA HHHHHHHHHHHHHCC | 60.72 | - | |
668 | Ubiquitination | VEDRLQEKAADTIEA HHHHHHHHHHHHHHH | 35.59 | 21906983 | |
672 | Phosphorylation | LQEKAADTIEALQKA HHHHHHHHHHHHHHC | 18.91 | 27174698 | |
678 | Ubiquitination | DTIEALQKAGIKVWV HHHHHHHHCCCEEEE | 49.81 | 21890473 | |
702 | Ubiquitination | AATCYACKLFRRNTQ HHHHHHHHHHHHCCH | 42.35 | 21890473 | |
708 | Phosphorylation | CKLFRRNTQLLELTT HHHHHHCCHHHHHHH | 20.84 | 21659604 | |
714 | Phosphorylation | NTQLLELTTKRIEEQ CCHHHHHHHHHHHHC | 22.39 | - | |
715 | Phosphorylation | TQLLELTTKRIEEQS CHHHHHHHHHHHHCC | 30.83 | - | |
716 | Ubiquitination | QLLELTTKRIEEQSL HHHHHHHHHHHHCCH | 46.25 | 21890473 | |
732 | Ubiquitination | DVLFELSKTVLRHSG HHHHHHHHHHHHHCC | 56.10 | - | |
733 | Phosphorylation | VLFELSKTVLRHSGS HHHHHHHHHHHHCCC | 22.77 | 23663014 | |
738 | Phosphorylation | SKTVLRHSGSLTRDN HHHHHHHCCCCCCCC | 24.52 | 10470851 | |
740 | Phosphorylation | TVLRHSGSLTRDNLS HHHHHCCCCCCCCCC | 29.58 | 25159151 | |
742 | Phosphorylation | LRHSGSLTRDNLSGL HHHCCCCCCCCCCCC | 37.36 | 23663014 | |
747 | Phosphorylation | SLTRDNLSGLSADMQ CCCCCCCCCCCCCHH | 43.90 | 28857561 | |
750 | Phosphorylation | RDNLSGLSADMQDYG CCCCCCCCCCHHHHE | 26.25 | 28857561 | |
756 | Phosphorylation | LSADMQDYGLIIDGA CCCCHHHHEEEEECH | 9.28 | 28857561 | |
766 | Phosphorylation | IIDGAALSLIMKPRE EEECHHHHEEECCCC | 15.89 | 28857561 | |
776 | Phosphorylation | MKPREDGSSGNYREL ECCCCCCCCCCHHHH | 47.60 | - | |
777 | Phosphorylation | KPREDGSSGNYRELF CCCCCCCCCCHHHHH | 36.27 | - | |
780 | Phosphorylation | EDGSSGNYRELFLEI CCCCCCCHHHHHHHH | 14.69 | - | |
809 | Ubiquitination | LQKAQIVKLIKFSKE CCHHHHHHHHHHCCC | 46.23 | 21890473 | |
812 | Ubiquitination | AQIVKLIKFSKEHPI HHHHHHHHHCCCCCE | 54.76 | - | |
854 | Phosphorylation | GRQAARNSDYAIPKF HHHHHHCCCCCCCHH | 26.84 | 27251275 | |
949 | Phosphorylation | DVLKRDPTLYRDVAK HHHCCCCCCHHHHHH | 40.48 | 21815630 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AT11A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AT11A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AT11A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CC50A_HUMAN | TMEM30A | physical | 21914794 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...